Somerset Therapeutics
4 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Somerset Therapeutics and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-03-25FDA-DrugClass IIStop using Somerset Therapeutics dexamethasone injection
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
- 2025-12-24FDA-DrugClass IIIStop using Somerset Therapeutics cisatracurium besylate
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugClass IIIStop using Somerset cisatracurium besylate injection
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugClass IIICheck cisatracurium besylate vials for affected lots
Subpotent product:out of specification assay results observed during long term stability testing.
Get notified about new Somerset Therapeutics recalls
Free weekly digest. We email when a new federal recall affects Somerset Therapeutics or anything else in your household.
Get the Sunday Brief